Marie-Elise T.
- Country
- France
- Department
- Service de Rhumatologie
Research Overview
- Tulisokibart in Systemic Sclerosis-Associated Interstitial Lung Disease: A Randomized, Placebo-Controlled Trial of Safety and Efficacy
- Rituximab Maintenance Therapy versus Placebo in Patients with Stabilized Systemic Sclerosis–Associated Interstitial Lung Disease after Induction
- Phase 3 Randomized Study of CD19‑Targeted NEX‑T CAR T (CC‑97540) vs Standard‑of‑Care Combination Therapy in Systemic Sclerosis–Associated Interstitial Lung Disease
Data & Insights
Has run more than one trial at 157 of 353 partner sites.
Specializations
Systemic Sclerosis Research
Specializes in investigating novel treatments for diffuse cutaneous systemic sclerosis, with particular focus on skin fibrosis and lung function improvements. The investigator studies innovative therapeutic approaches including LPAR1 antagonists and selective JAK inhibitors.
- Skin Fibrosis Management
- Pulmonary Complications
- Ectopic Calcifications
Autoinflammatory Conditions
Conducts research in rare genetic autoinflammatory disorders including NLRC4-GOF, XIAP deficiency, and CDC42 mutations. The investigator explores treatment options for Familial Mediterranean Fever, particularly in colchicine-resistant cases.
- Genetic Inflammatory Disorders
- Inflammatory Attack Prevention
- Novel Therapeutic Approaches
Gout Management
Focuses on developing treatments for acute gout flares and chronic hyperuricemia. Special attention is given to gout management in patients with complex conditions such as chronic kidney disease and transplant recipients.
- Acute Flare Treatment
- Hyperuricemia Control
- Renal Complications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.